Skip to main content
Equibles

WELLS FARGO & COMPANY/MN

Position in SGMT — Sagimet Biosciences Inc.

CIK 72971 SAN FRANCISCO, CA
Back to SGMT Full portfolio

Position in SGMT

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$494,688
+$446,232 QoQ
Shares Held
63,996
+590.1% QoQ
Ownership
0.103%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#57
of 122 holders
Holding Since
Sep 2023
10 quarters on record
Voting authority Sole 98% Shared 0% None 2%

Common Shares in SGMT Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

WELLS FARGO & COMPANY/MN holds $1,575,562,942 across 417 Biotechnology names. SGMT ranks #186 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 749,528 $372,313,040
2 HALO
Halozyme Therapeutics, Inc.
 1,390,428 $108,828,797
3 ALNY
Alnylam Pharmaceuticals, Inc.
 310,047 $93,333,446
4 REGN
Regeneron Pharmaceuticals, Inc.
 140,802 $87,795,677
5 EXEL
Exelixis, Inc.
 717,840 $39,057,673
6 RVMD
Revolution Medicines, Inc.
 178,780 $33,481,916
7 ARGX
Argenx SE
 34,453 $31,964,458
8 INCY
Incyte Corp
 255,064 $28,914,053

All Filings in SGMT

Export CSV
10 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $494,688 63,996
2026-03-31 $48,456 9,274
2025-12-31 $47,360 8,000
2025-09-30 $48,020 7,000
2025-06-30 $49,530 6,500
2025-03-31 $57,050 17,500
2024-12-31 $30,645 6,810
2024-03-31 $40,752 7,519
2023-12-31 $8,606 1,588
2023-09-30 $10,692 1,215